Common heartburn drug may have helped
10 patients at home with Covid-19
In the report, published Thursday in the medical journal Gut, all but one of the study subjects took the drug within 10 days of first experiencing symptoms such as cough and shortness of breath. The 10th patient took it 26 after symptoms began. They were between the ages of 23 and 71.
"All patients noticed a rapid improvement in their condition within 24 to 48 hours of starting famotidine," according to the report. "These findings suggest that famotidine may affect the course of COVID-19."
Cancer, coronavirus are a dangerous mix,
new studies find
New research shows how dangerous the coronavirus is for current and former cancer patients. Those who developed COVID-19 were much more likely to die within a month than people without cancer who got it, two studies found.
They are the largest reports on people with both diseases in the United States, the United Kingdom, Spain and Canada. In one study, half of 928 current and former cancer patients with COVID-19 were hospitalized and 13% died. That’s far more than the various rates that have been reported in the general population.
Vitamin D determines severity in COVID-19 so government advice needs to change, experts urge
is2020over.com.
NO
January | |
February | |
March |
|
April |
|
May |
|
June |
|
July | |
August | |
September | |
October | |
November | |
December |
No comments:
Post a Comment